NAN 1.56% $3.15 nanosonics limited

Another brick in the wall, page-15

  1. 305 Posts.
    lightbulb Created with Sketch. 7
    US growth may be a bit bumpy due to healthcare reforms
    UK growth won't see immediate revenue but will see ongoing and higher revenue due to model
    R&D and expenses due to international growth

    Overall, solid report and Nanosonics focused on long term dominant position instead of short term bottom line - how it should be!
 
watchlist Created with Sketch. Add NAN (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.